GYNO-TARDYFERON

This brand name is authorized in Cyprus, Turkey

Active ingredients

The drug GYNO-TARDYFERON contains a combination of these active pharmaceutical ingredients (APIs):

1 Ferrous sulfate sesquihydrate
UNII 39R4TAN1VT - FERROUS SULFATE

Iron sulphate is a co-factor of various enzymes necessary for the transfer of energy (eg. cytochrome oxidase, xanthine oxidase). Iron is also present in hemoglobin and myoglobin, which are essential for the transport and use of oxygen.

Read about Ferrous sulfate
2 Folic acid
UNII 935E97BOY8 - FOLIC ACID

Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues.

Read about Folic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B03AD03 Ferrous sulfate and folic acid B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AD Iron in combination with folic acid
Discover more medicines within B03AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8699749140027

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.